- Previous Close
30.97 - Open
30.53 - Bid 31.40 x --
- Ask 31.60 x --
- Day's Range
30.53 - 31.88 - 52 Week Range
26.10 - 41.00 - Volume
14,600 - Avg. Volume
8,332 - Market Cap (intraday)
313.3M - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
-- - EPS (TTM)
-0.04 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products. The company also provides ready-to-fill pellets and multiple unit pellets system; drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. Concord Drugs Limited was incorporated in 1995 and is based in Hyderabad, India.
concorddrugs.in185
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: CONCORD.BO
View MorePerformance Overview: CONCORD.BO
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CONCORD.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CONCORD.BO
View MoreValuation Measures
Market Cap
309.70M
Enterprise Value
497.66M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.61
Price/Book (mrq)
0.91
Enterprise Value/Revenue
0.99
Enterprise Value/EBITDA
14.41
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.08%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
504.95M
Net Income Avi to Common (ttm)
-416k
Diluted EPS (ttm)
-0.04
Balance Sheet and Cash Flow
Total Cash (mrq)
535k
Total Debt/Equity (mrq)
56.35%
Levered Free Cash Flow (ttm)
--